ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding ADC Therapeutics SA changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 115 | 2 | 118 | +5 |
| Shares | 82.9M | 1.81M | 83.5M | +2.46M (+3.0%) |
| Value | $292.8M | $6.40M | $312.9M | +$26.5M (+9.2%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held ADC Therapeutics SA at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Portfolio Management LLC | 1,033,277 | $3.87M | 0.00% |
| Renaissance Technologies LLC | 299,278 | $1.12M | 0.00% |
| Lazard Asset Management LLC | 262,595 | $984.7K | 0.00% |
| Vanguard Fiduciary Trust Co | 88,907 | $333.4K | 0.00% |
| Balyasny Asset Management LLC | 77,947 | $292.3K | 0.00% |
| Walleye Capital LLC | 77,390 | $290.2K | 0.00% |
| Marshall Wace, LLP | 45,479 | $170.5K | 0.00% |
| Dynamic Technology Lab Private Ltd | 43,970 | $164.9K | 0.03% |
| Vanguard Global Advisers, LLC | 31,593 | $118.5K | 0.00% |
| Prudential Financial Inc | 26,295 | $98.6K | 0.00% |
| Graham Capital Management, L.P. | 22,442 | $84.2K | 0.00% |
| Aquatic Capital Management LLC | 16,718 | $62.7K | 0.00% |
| Virtu Financial LLC | 12,098 | $45.0K | 0.00% |
| R Squared Ltd | 10,119 | $37.9K | 0.02% |
| State of Wyoming | 2,032 | $7.62K | 0.00% |
| C M Bidwell & Associates Ltd | 1,119 | $4.20K | 0.00% |
| Root Financial Partners, LLC | 89 | $334 | 0.00% |
| Caitong International Asset Management Co., Ltd | 2 | $8 | 0.00% |
| Twin Peaks Wealth Advisors, LLC | 2 | $8 | 0.00% |
Sold out (14)
Institutions that held ADC Therapeutics SA at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| StemPoint Capital LP | 502,570 | $1.77M |
| Two Sigma Advisers, LP | 120,567 | $425.6K |
| SG Americas Securities, LLC | 24,448 | $86.0K |
| Gsa Capital Partners LLP | 20,889 | $74.0K |
| Henrickson Nauta Wealth Advisors, Inc. | 19,411 | $68.7K |
| Axq Capital, LP | 16,078 | $56.8K |
| Ieq Capital, LLC | 16,067 | $56.7K |
| Engineers Gate Manager LP | 12,071 | $42.6K |
| Amalgamated Bank | 2,710 | $10.0K |
| Simplex Trading, LLC | 2,687 | $9.48K |
| Los Angeles Capital Management LLC | 1,725 | $7.99K |
| SBI Securities Co., Ltd. | 222 | $784 |
| Farther Finance Advisors, LLC | 57 | $201 |
| SRS Capital Advisors, Inc. | 17 | $60 |
Not filed for Q1 2026 yet (2)
Institutions that held ADC Therapeutics SA at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,129,587 | $3.99M |
| Vantage Consulting Group Inc | 682,998 | $2.41M |